Evaluation of oral pregabalin administration on pain of patients undergoing prostate biopsy

Evaluation of oral pregabalin and local anesthesia simultaneous administration effect on pain of patients undergoing prostate biopsy refered to imam hospital of Urmia

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200205046388N1

Enrollment

Registered

2020-11-16

Start date

2020-11-10

Completion date

Unknown

Last updated

2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer. Malignant neoplasm of prostate

Interventions

Intervention 1: Intervention group: single dose of PREGABALIN SOBHAN DAROU (Iran), 100MG CAP will prescribe in patients which be under routine TRUS biopsy prostate with Lidocaine local anesthesia

Eligibility

Sex/Gender

Male

Age

20 Years to No maximum

Inclusion criteria

Inclusion criteria: Male patients with PSA =4.0 ng/mL Lithotomy position for prostate biopsy is possible for participants

Exclusion criteria

Exclusion criteria: Prior pelvic pain before prostate biopsy TURP history Hormonal therapy or radiotherapy history Existing any Ano-rectal pathology

Design outcomes

Primary

Measure	Time frame
Pain after prostate biopsy. Timepoint: 1 and 6 hours after biopsy. Method of measurement: Pain Analogue Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTayyebi Azar Ali

Oroumia University of Medical Sciences

ali.tyazar@gmail.com+98 44 3198 8749

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026